Position in JNJ
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$52,716,806
+$1,092,056 QoQ
Shares Held
207,571
-1.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
#434
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. JNJ ranks #1 (31.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,716,806 | 207,571 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $51,624,750 | 211,196 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $44,442,305 | 214,749 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $40,429,533 | 218,043 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,736,365 | 220,860 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $37,833,742 | 228,134 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $34,656,881 | 239,641 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $39,378,472 | 242,987 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $36,483,728 | 249,615 | Shares | Other | 2024-08-07 | |
| 2024-03-31 | $39,644,312 | 250,612 | Shares | Other | 2024-04-17 | |
| 2023-12-31 | $40,055,220 | 255,552 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $39,823,561 | 255,689 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $42,667,414 | 257,778 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $40,042,545 | 258,339 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $45,923,170 | 259,967 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $43,671,028 | 267,330 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $48,626,201 | 273,935 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $48,861,602 | 275,696 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $47,320,528 | 276,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $44,724,033 | 276,929 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $46,152,240 | 280,152 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $46,854,212 | 285,088 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $44,951,819 | 285,626 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $43,179,815 | 290,031 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $40,947,237 | 291,170 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $38,415,189 | 292,955 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||